Common Stock, Shares, Outstanding of ENZO BIOCHEM INC from 31 Jul 2012 to 30 Apr 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ENZO BIOCHEM INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Jul 2012 to 30 Apr 2025.
  • ENZO BIOCHEM INC Common Stock, Shares, Outstanding for the quarter ending 30 Apr 2025 was 52,402,804, a 2.3% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ENZO BIOCHEM INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 52,402,804 +1,175,269 +2.3% 30 Apr 2025 10-Q 16 Jun 2025 2025 Q3
Q4 2024 52,402,804 +1,913,033 +3.8% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q2
Q3 2024 52,244,074 +1,754,303 +3.5% 31 Oct 2024 10-Q 16 Dec 2024 2025 Q1
Q2 2024 52,244,074 +2,246,443 +4.5% 31 Jul 2024 10-Q 16 Jun 2025 2025 Q3
Q1 2024 51,227,535 +1,558,047 +3.1% 30 Apr 2024 10-Q 13 Jun 2024 2024 Q3
Q4 2023 50,489,771 +1,756,717 +3.6% 31 Jan 2024 10-Q 13 Mar 2024 2024 Q2
Q3 2023 50,489,771 +1,769,317 +3.6% 31 Oct 2023 10-Q 15 Dec 2023 2024 Q1
Q2 2023 49,997,631 +1,277,177 +2.6% 31 Jul 2023 10-K 29 Oct 2024 2024 FY
Q1 2023 49,669,488 +949,034 +1.9% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q3
Q4 2022 48,733,054 +261,283 +0.54% 31 Jan 2023 10-Q 20 Mar 2023 2023 Q2
Q3 2022 48,720,454 +248,683 +0.51% 31 Oct 2022 10-Q 12 Dec 2022 2023 Q1
Q2 2022 48,720,454 +248,683 +0.51% 31 Jul 2022 10-K 03 Nov 2023 2023 FY
Q1 2022 48,720,454 +248,683 +0.51% 30 Apr 2022 10-Q 09 Jun 2022 2022 Q3
Q4 2021 48,471,771 +244,021 +0.51% 31 Jan 2022 10-Q 14 Mar 2022 2022 Q2
Q3 2021 48,471,771 +576,721 +1.2% 31 Oct 2021 10-Q 15 Dec 2021 2022 Q1
Q2 2021 48,471,771 +576,721 +1.2% 31 Jul 2021 10-K 14 Oct 2022 2022 FY
Q1 2021 48,471,771 +580,888 +1.2% 30 Apr 2021 10-Q 11 Jun 2021 2021 Q3
Q4 2020 48,227,750 +670,132 +1.4% 31 Jan 2021 10-Q 16 Mar 2021 2021 Q2
Q3 2020 47,895,050 +338,243 +0.71% 31 Oct 2020 10-Q 11 Dec 2020 2021 Q1
Q2 2020 47,895,050 +338,243 +0.71% 31 Jul 2020 10-K 12 Oct 2021 2021 FY
Q1 2020 47,890,883 +334,076 +0.7% 30 Apr 2020 10-Q 09 Jun 2020 2020 Q3
Q4 2019 47,557,618 +316,283 +0.67% 31 Jan 2020 10-Q 06 Mar 2020 2020 Q2
Q3 2019 47,556,807 +364,378 +0.77% 31 Oct 2019 10-Q 10 Dec 2019 2019 Q1
Q2 2019 47,556,807 +374,553 +0.79% 31 Jul 2019 10-K 19 Oct 2020 2020 FY
Q1 2019 47,556,807 +394,865 +0.84% 30 Apr 2019 10-Q 10 Jun 2019 2019 Q3
Q4 2018 47,241,335 +270,406 +0.58% 31 Jan 2019 10-Q 11 Mar 2019 2019 Q2
Q3 2018 47,192,429 +278,897 +0.59% 31 Oct 2018 10-Q 10 Dec 2018 2019 Q1
Q2 2018 47,182,254 +676,078 +1.5% 31 Jul 2018 10-K 15 Oct 2019 2019 FY
Q1 2018 47,161,942 +754,611 +1.6% 30 Apr 2018 10-Q 11 Jun 2018 2018 Q3
Q4 2017 46,970,929 +678,713 +1.5% 31 Jan 2018 10-Q 12 Mar 2018 2018 Q2
Q3 2017 46,913,532 +633,745 +1.4% 31 Oct 2017 10-Q 07 Dec 2017 2018 Q1
Q2 2017 46,506,176 +238,557 +0.52% 31 Jul 2017 10-K 15 Oct 2018 2018 FY
Q1 2017 46,407,331 +152,461 +0.33% 30 Apr 2017 10-Q 08 Jun 2017 2017 Q3
Q4 2016 46,292,216 +199,698 +0.43% 31 Jan 2017 10-Q 13 Mar 2017 2017 Q2
Q3 2016 46,279,787 +210,971 +0.46% 31 Oct 2016 10-Q 08 Dec 2016 2017 Q1
Q2 2016 46,267,619 +205,554 +0.45% 31 Jul 2016 10-K 27 Sep 2017 2017 FY
Q1 2016 46,254,870 +196,804 +0.43% 30 Apr 2016 10-Q 08 Jun 2016 2016 Q3
Q4 2015 46,092,518 +718,444 +1.6% 31 Jan 2016 10-Q 09 Mar 2016 2016 Q2
Q3 2015 46,068,816 +1,317,217 +2.9% 31 Oct 2015 10-Q 08 Dec 2015 2015 Q1
Q2 2015 46,062,065 +1,822,882 +4.1% 31 Jul 2015 10-K 13 Oct 2016 2016 FY
Q1 2015 46,058,066 30 Apr 2015 10-Q 09 Jun 2015 2015 Q3
Q4 2014 45,374,074 31 Jan 2015 10-Q 12 Mar 2015 2015 Q2
Q3 2014 44,751,599 31 Oct 2014 10-Q 09 Dec 2014 2015 Q1
Q2 2014 44,239,183 +44,239,183 31 Jul 2014 10-K 13 Oct 2015 2015 FY
Q2 2013 0 0 31 Jul 2013 10-K 15 Oct 2013 2013 FY
Q2 2012 0 31 Jul 2012 10-K 15 Oct 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.